MHRA sets out approach to strengthen patient and public involvement and engagement in medicines and medical device regulation
Safety Classified by Officially
Patients and the public will have a greater role in shaping medicines and medical device regulation under a new plan published today by the Medicines and Healthcare products Regulatory Agency (MHRA).
The Patient and Public Involvement and Engagement Plan 2026–2030 (PPIE), a key tenet of the MHRA’s Strategy 2030, sets out how the agency will involve and engage people earlier, hear from a wider range of patient groups and communities and explain openly and clearly how patients’ experiences shape its work.
Patients’ lived experience will help inform decisions at the MHRA, including the assessment of medicine benefits and risks, safety reviews, regulatory policy, patient information and the development of regulatory approaches for rare diseases, medical devices, future regulatory pathways, artificial intelligence (AI) and other emerging technologies.
The plan supports the MHRA’s newly-published Strategy to 2030, builds on its Patient Involvement Strategy 2021–2025 and responds to feedback calling for more inclusive participation and information on how patient involvement shapes regulatory decisions.
Strengthen feedback, monitoring and reporting so people can see how their contributions have influenced the MHRA’s work.
Expand membership of its Patient and Public Community to better reflect the diversity of the UK population.
Use deliberative engagement to ensure patient and public perspectives shape how the benefits and risks of medicines are assessed.
Involve patients and the public in work to make medicines information clearer and more accessible.
Work with the National Institute for Health and Care Excellence (NICE) to reduce duplication in patient involvement evidence used for regulatory and health technology assessments.
Professor Anthony Harnden, Chair of the MHRA, said:
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/news/mhra-sets-out-approach-to-strengthen-patient-and-public-involvement-and-engagement-in-medicines-and-medical-device-regulation
Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Medicines and Healthcare products Regulatory Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
- Imported
- November 05, 2026 17:02
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/news/mhra-sets-out-approach-to-strengthen-patient-and-pub...